2011 annual financial data
Xenon Pharmaceuticals 2011 Operating margin
Direct answer
Operating margin was -175.11%.
Operating income was -12,114,000 USD and net income was -11,992,000 USD.
Operating cash flow was -13,689,000 USD.
Get free Xenon Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,918,000 USD
- Operating income
- -12,114,000 USD
- Net income
- -11,992,000 USD
- Operating cash flow
- -13,689,000 USD